BNT211: a Phase 1 Study to determine the Safety and Efficacy of CLDN6 CAR T Cells and CARVAC-mediated in vivo Expansion in Patients with CLDN6-positive advanced solid Tumors

Haanen, J. B. and Mackensen, A. and Koenecke, C. and Alsdorf, W. and Wagner-Drouet, E. and Heudobler, Daniel and Borchmann, P. and Klobuch, S. and Smit, E. and Bokemeyer, C. and Desuki, A. and Lüke, Florian and Wiegert, E. and Schulz-Eying, C. and Rengstl, B. and Preussner, L. and Türeci, Ö. and Sahin, U. (2022) BNT211: a Phase 1 Study to determine the Safety and Efficacy of CLDN6 CAR T Cells and CARVAC-mediated in vivo Expansion in Patients with CLDN6-positive advanced solid Tumors. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Speech)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 11 Oct 2023 06:14
Last Modified: 11 Oct 2023 06:14
URI: https://pred.uni-regensburg.de/id/eprint/58309

Actions (login required)

View Item View Item